SB3323 - 104th General Assembly (2025-2026)

CONTROLLED SUB-TESTOSTERONE
Last Action
2/17/2026 - Senate: Assigned to Executive
Statutes Amended In Order of Appearance
720 ILCS 570/316  
720 ILCS 570/316.2 new  
Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.
Actions
DateChamberAction
2/03/2026SenateFiled with Secretary by Sen. Adriane Johnson
2/03/2026SenateFirst Reading
2/03/2026SenateReferred to Assignments
2/11/2026SenateAdded as Co-Sponsor Sen. Rachel Ventura
2/17/2026SenateAssigned to Executive